Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 7
Submit an article Journal homepage
218
Views
12
CrossRef citations to date
0
Altmetric
Future Perspective

JAA-F11

extending the life of mice with breast cancer

Kate Rittenhouse-Olson University at Buffalo, Department of Biotechnical and Clinical Laboratory Sciences and Department of Microbiology, 26 Cary Hall, Buffalo, NY 14214, USA +1 716 829 3630; +1 716 829 3601; [email protected]
Pages 923-928 | Published online: 31 Jul 2007

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohamad Salih Jaff. (2010) Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseases. International Journal of Nanomedicine 5, pages 901-905.
Read now
Kristel Kodar, Oleg Kurtenkov & Kersti Klaamas. (2009) The Thomsen-Friedenreich Antigen and αGal-specific Human IgG Glycoforms: Concanavalin A Reactivity and Relation to Survival of Cancer Patients. Immunological Investigations 38:8, pages 704-717.
Read now

Articles from other publishers (10)

Diala Ghazal, Fatma Zalzala, John C. Fisk, Swetha Tati, Loukia G. Karacosta, Susan Morey, James R. Olson, Sally Quataert, Grace K. Dy & Kate Rittenhouse-Olson. (2022) Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models. Oncotarget 13:1, pages 1155-1164.
Crossref
Utpal K. Mondal & Joseph J. BarchiJrJr. (2022) Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies. Frontiers in Chemistry 10.
Crossref
Nora Berois, Alvaro Pittini & Eduardo Osinaga. (2022) Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers 14:3, pages 645.
Crossref
Sabine Heublein, Markus Egger, Junyan Zhu, Luisa Berger, Doris Mayr, Christian Schindlbeck, Christina Kuhn, Simone S. Hofmann, Florian Schuetz, Udo Jeschke & Nina Ditsch. (2019) Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer. Breast Cancer Research and Treatment 179:3, pages 643-652.
Crossref
Kevin R. Trabbic, Kaitlyn Whalen, Karin Abarca-Heideman, Li Xia, J. Sebastian Temme, Elijah F. Edmondson, Jeffrey C. Gildersleeve & Joseph J. BarchiJr.Jr.. (2019) A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide. Scientific Reports 9:1.
Crossref
Sabine Heublein, Sabina K. Page, Doris Mayr, Nina Ditsch & Udo Jeschke. (2016) p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer. Journal of Cancer Research and Clinical Oncology 142:6, pages 1163-1170.
Crossref
Souvik Biswas, Scott H. Medina & Joseph J. BarchiJr.Jr.. (2015) Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles. Carbohydrate Research 405, pages 93-101.
Crossref
Kimiko Ferguson, Arti Yadav, Susan Morey, Julia Abdullah, Gabriel Hrysenko, Jing Ying Eng, Munawwar Sajjad, Stephen Koury & Kate Rittenhouse-Olson. (2014) Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer. Future Oncology 10:3, pages 385-399.
Crossref
AC O'Farrell, SD Shnyder, G Marston, PL Coletta & JH Gill. (2013) Non-invasive molecular imaging for preclinical cancer therapeutic development. British Journal of Pharmacology 169:4, pages 719-735.
Crossref
Ning Li, Moonhee Park, Minglang Zhao, Julio Hilario-Vargas, David M. McInnes, Phillip S. Prisayanh, Zhi Liu & Luis A. Diaz. (2010) The Thomsen-Friedenreich Antigen-Binding Lectin Jacalin Interacts with Desmoglein-1 and Abrogates the Pathogenicity of Pemphigus Foliaceus Autoantibodies In Vivo. Journal of Investigative Dermatology 130:12, pages 2773-2780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.